Building Capacity for Deprescribing Guideline Development, Implementation, and Evaluation

This knowledge mobilization grant supported a variety of strategies designed to help healthcare providers and members of the public use deprescribing guidelines effectively. These included whiteboard training videos, mobile apps, webinars, a wide-reaching social media strategy and interactive learning events. The centrepiece was an international three-day symposium held in March 2018 in Ottawa, Canada. Guideline developers, healthcare providers, people leading implementation pilots and public engagement strategies, educators, researchers, decision-makers, and members of the public participated. For more about this event, visit our Deprescribing Symposium Resources page.

Lead: Dr. Barbara Farrell, Bruyère Research Institute

Co-investigators: Dr. Lisa McCarthy, Dr. James Conklin, Dr. Lisa Dolovich, Dr. Lalitha Raman-Wilms, Dr. Emily Reeve, Dr. Frank MoriartyDr. Kevin Pottie, Dr. Lise Bjerre, Dr. Vivian Welch, Dr. Roland Grad


Funder (2017-2019): Knowledge Mobilization Partnership Program, Centre for Aging and Brain Health Innovation

  • Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W. Deprescribing guidelines: An international symposium on development, implementation, research and health professional education. Research in Social and Administrative Pharmacy,
  • Raman-Wilms L, Farrell B, Sadowski C, Austin Z. Deprescribing: An educational imperative. Research in Social and Administrative Pharmacy,
  • Conklin J, Farrell B, Suleman S. Implementing deprescribing guidelines into frontline practice: Barriers and facilitators. Research in Social and Administrative Pharmacy,
  • Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, A. Steinman M, Conklin J, Dolovich L, McCarthy L, Farrell B. Deprescribing: Future directions for research. Research in Social and Administrative Pharmacy,
  • Moriarty F, Pottie K, Dolovich L, McCarthy L, Rojas-Fernandez C, Farrell B. Deprescribing recommendations: An essential consideration for clinical guideline developers. Research in Social and Administrative Pharmacy,